SciELO - Scientific Electronic Library Online

 
vol.39 issue4Peduncular hallucinosis in multiple sclerosis, a rare symptom in demyelinating diseaseUpdate on migraine-depression comorbidity author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Acta Neurológica Colombiana

Print version ISSN 0120-8748On-line version ISSN 2422-4022

Abstract

MONTIEL, Luis Salgado; RIOS-OZUNA, Jhonnys; CABRALES-JUAN, José  and  FRANCO-DAGER, Edwing. Positive and negative myoclonus in a patient with end stage renal disease. Acta Neurol Colomb. [online]. 2023, vol.39, n.4, e8.  Epub Jan 20, 2024. ISSN 0120-8748.  https://doi.org/10.22379/anc.v39i4.860.

Introduction:

Myoclonus are paroxysmal muscle contractions of short duration or abrupt loss of muscle tone, called positive and negative myoclonus respectively. A clinical case of generalized positive and negative myoclonus is presented and the aim is to describe the multiple pathophysiological mechanisms and etiologies that trigger it.

Case presentation:

A 35-year-old man with type 1 diabetes mellitus complicated by diabetic kidney disease on hemodialysis developed catheter-associated bacteremia due to Staphylococcus aureus and presented positive and negative myoclonus. Uremia, infection, and drugs with pro-myoclonic potential were identified as possible triggers; The incidental finding of an ischemic lesion in the caudate nucleus did not explain the semiology found in the patient. The control and removal of all the pro-myoclonic factors mentioned was carried out, along with pharmacological management with levetiracetam, thus achieving control of the symptoms.

Discussion:

Patients with chronic kidney disease are susceptible to the accumulation of guanidine-type toxic products, which have the potential to produce myoclonus. Furthermore, infections, the use of drugs with pro-myoclonic potential and structural lesions such as cortical ischemia are etiologies that should be considered in the differential diagnosis. The greatest impact on symptoms is observed with the control of the triggering factor and if it persists, pharmacological therapy provides good results.

Conclusion:

Myoclonus are relatively common movement disorders in chronic kidney disease. Identification of the trigger is crucial for its management along with the use of drugs with anti-myoclonic activity.

Keywords : Chronic kidney disease; Myoclonus; opioid analgesics; Cephalosporins; Gabapentin; Dialysis; Guanidine; Levetiracetam; Uremia.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )